The Hindu·4 min read·medium

FDA panel narrowly backs unapproved peptide drugs favoured by RFK Jr and wellness influencers

A
AP
FDA panel narrowly backs unapproved peptide drugs favoured by RFK Jr and wellness influencers
AI Summary

An FDA advisory panel has recommended easing restrictions on the compounding of certain injectable peptides, despite warnings from agency scientists regarding safety and efficacy. The move is supported by Robert F. Kennedy Jr. and industry-linked panel members.

A panel of federal health advisers on Thursday narrowly recommended easing access to several peptides popular with wellness influencers and celebrities, despite warnings from government scientists that the chemicals haven't been shown safe or effective.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthpolitics

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in